Skip to main content

Table 1 A summary of published studies comparing head growth in children with autism vs. controlsa

From: Infant head growth in male siblings of children with and without autism spectrum disorders

Study

n ASDa

Dev. period of measurement (months)

Mean IQ of subjects

Control group

Method of measurement

1st year of life principle findings

12–36 month significant findings

Analytic methodb

1. Courchesne et al. 2003

48

Birth—14

75

CDC Norms/FELS longitudinal sample study

OFC and MRI

Birth-14 month (acceleration)

 

Cross-sectional

2. Torrey et al. 2004

15

Birth—14

56.8

NCPP (1959–1965 birth cohorts)

OFC

Difference at birth but no difference in growth trajectory

[no difference]

Cross-sectional, growth curve

3. Hazlett et al. 2005

113

Birth—36

54.1

Contemporaneous controls with TYP (n = 178) or DD (n = 11)

OFC and MRI

[no difference]

12–24 months (acceleration)

Cross- sectional, growth curve analysis

4. Fukumoto et al. 2008

85

Birth—12

75.5

JMHLW 2000 infant physical growth survey

OFC

1–12 month (acceleration)

 

Cross-sectional

5. Elder et al. 2008 (Study of 77 high- risk sibs)

Not Reported

Birth—24

Not Reported

2002 CDC Norms

OFC

Birth-12 month (acceleration)

12–24 months (deceleration)

Cross-sectional, multilevel modeling

6. Dawson et al. 2007 (deceleration)

28

Birth—36

61.5 (Mullen Composite)

2002 CDC Norms

OFC

Birth-12 month (acceleration)

12—36 months (relative deceleration)

Cross-sectional, growth curve

7. Webb et al. 2007

28

Birth—36

Not Reported

2000 CDC Norms

OFC

7–10 month (acceleration)

 

Cross-sectional

8. van Daalen et al. 2007

53

Birth—64

<70: 33 70–85:6

1996, 1997 NOASR

OFC

[no difference]

[no difference]

Cross-sectional

>85: 14

9. Constantino et al. [Current Study]

48

Birth—36

92

Unaffected sibs and contemporaneous control sib pairs

OFC

Birth—15 month (trend, acceleration)

 

Cross-sectional, growth curve

  1. aNumber of ASD-affected subjects from unique families
  2. bP-Values for principal differences between ASD subjects and controls
  3. 1. Comparison of 22 ASD infants vs. 31 controls with birth—14 month data indicated a significantly greater increase in HC, p < .001
  4. 2. At 4 months, the HC of the ASD subjects was not significantly larger than the HC of the controls (p = .07)
  5. 3. The growth curves for subjects with autism vs. controls were significantly different; p < .001 for all three parameters comprising the curves
  6. 4. In the low functioning ASD boys, HC differed from the controls at 1 month (p = .0008), 3 months (p = .025), and 6 months (p = .0001). The high functioning ASD boys differed from the controls at 6 months (p = .02)
  7. 5. Whole group cross-sectional differences between high risk siblings and CDC norms are significantly different at 6–12 months, p < .05 at each time point; birth—12 month slopes are greater than CDC norms, p < .001. Subset with significant ASD symptoms (Early Developmental Interview, EDI or Modified Checklist for Autism in Toddlers, M-CHAT) vs. those without differed in 12–24 month HC slope (EDI, p = .05), and exhibited a larger 12 month intercept (M-CHAT, p = .02)
  8. 6. The orbitofrontal circumference (OFC) z-score for the ASD subjects at 12 months was significantly larger than the control group’s (p < .001). Although the rate of change of HC decreases from 12–36 months (p = .001), the rate of change does not significantly differ from that of the norms (p = .409)
  9. 7. The mean OFC z-scores in the ASD group did not significantly differ from the controls from 0–7 months and from 10–13 months, but they were significantly larger than the controls from 7–10 (p < .001) and 13–36 (p < .007) months
  10. 8. No significant difference between ASD subjects and controls were found
  11. 9. Growth curve trajectory for ASD subjects mildly accelerated in comparison controls for age range birth—15 months, p=.07. The magnitude of difference was on the order of 0.03 cm/month